WEST PHARMACEUTICAL SERVICES, INC. Treasury Stock Acquired, Average Cost Per Share
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Treasury Stock Acquired, Average Cost Per Share of $258.03 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:TreasuryStockAcquiredAverageCostPerShare · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for the quarter ending 2026-03-31 was $243.57, a 0.39% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for the quarter ending 2025-06-30 was $222.56, a 39.44% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for the quarter ending 2025-03-31 was $242.63, a 33.68% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for the quarter ending 2024-09-30 was $306.34, a 14.96% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for fiscal 2025 was $242.55, a 31.54% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for fiscal 2024 was $354.30, a 2.30% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for fiscal 2023 was $346.34, a 3.80% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. treasury stock acquired, average cost per share for fiscal 2022 was $360.03, a 25.78% increase from fiscal 2021.
| Period end | Treasury Stock Acquired, Average Cost Per Share 3 month | Treasury Stock Acquired, Average Cost Per Share 6 month | Treasury Stock Acquired, Average Cost Per Share 9 month | Treasury Stock Acquired, Average Cost Per Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $258.03 10-Q · filed 2026-07-23 | |||
| 2026-03-31 | $243.57 10-Q · filed 2026-04-23 | |||
| 2025-12-31 | $242.55 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $242.55 10-Q · filed 2025-10-23 | |||
| 2025-06-30 | $222.56 10-Q · filed 2026-07-23 | $242.55 10-Q · filed 2026-07-23 | ||
| 2025-03-31 | $242.63 10-Q · filed 2026-04-23 | |||
| 2024-12-31 | $354.30 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $306.34 10-Q · filed 2025-10-23 | $359.24 10-Q · filed 2025-10-23 | ||
| 2024-06-30 | $367.48 10-Q · filed 2025-07-24 | $366.53 10-Q · filed 2025-07-24 | ||
| 2024-03-31 | $365.87 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | $345.56 10-K · filed 2024-02-20 | $346.34 10-K · filed 2025-02-18 | ||
| 2023-09-30 | $360.25 10-Q · filed 2024-10-24 | $346.86 10-Q · filed 2024-10-24 | ||
| 2023-06-30 | $351.82 10-Q · filed 2024-07-25 | $345.33 10-Q · filed 2024-07-25 | ||
| 2023-03-31 | $327.90 10-Q · filed 2024-04-25 | |||
| 2022-12-31 | $360.03 10-K · filed 2024-02-20 | |||
| 2022-09-30 | $313.22 10-Q · filed 2023-10-26 | $360.03 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $329.40 10-Q · filed 2023-07-27 | $368.54 10-Q · filed 2023-07-27 | ||
| 2022-03-31 | $377.23 10-Q · filed 2023-04-27 | |||
| 2021-12-31 | $286.23 10-K · filed 2022-02-22 | |||
| 2021-09-30 | $286.23 10-Q · filed 2021-10-28 | |||
| 2021-06-30 | $286.23 10-Q · filed 2021-07-30 | |||
| 2021-03-31 | $286.23 10-Q · filed 2021-04-30 | |||
| 2020-12-31 | $151.65 10-K · filed 2021-02-23 | |||
| 2020-09-30 | $151.65 10-Q · filed 2020-10-23 | |||
| 2020-06-30 | $151.65 10-Q · filed 2020-07-24 | |||
| 2020-03-31 | $151.65 10-Q · filed 2020-04-24 | |||
| 2019-12-31 | $103.89 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $103.89 10-Q · filed 2019-10-29 | |||
| 2019-06-30 | $103.89 10-Q · filed 2019-07-29 | |||
| 2019-03-31 | $103.89 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $88.51 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $88.51 10-Q · filed 2018-10-30 | |||
| 2018-06-30 | $88.03 10-Q · filed 2018-07-31 | $88.51 10-Q · filed 2018-07-31 | ||
| 2018-03-31 | $88.74 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $92.96 10-K · filed 2018-02-26 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-10-31 | $82.84 10-Q · filed 2017-10-31 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-01 | $82.84 10-Q · filed 2017-08-01 | ||
| 2017-03-31 | $82.84 10-Q · filed 2017-05-05 | |||
| 2016-12-31 | $74.54 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $81.46 10-Q · filed 2016-10-31 | $72.14 10-Q · filed 2016-10-31 | ||
| 2016-06-30 | $73.20 10-Q · filed 2016-08-01 | $67.82 10-Q · filed 2016-08-01 | ||
| 2016-03-31 | $63.66 10-Q · filed 2016-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |